Immunomodulatory Activity of Humanized Anti–IL-7r Monoclonal Antibody RN168 in Subjects With Type 1 Diabetes
JCI insight - United States
doi 10.1172/jci.insight.126054
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 19, 2019
Authors
Publisher
American Society for Clinical Investigation